| Literature DB >> 36120176 |
Pukar Khanal1, Basanagouda M Patil1.
Abstract
Objective: To report in vitro anti-oxidant activity and cytotoxicity of hydroalcoholic extract of Ficus benghalensis (bark) and Duranta repens (whole plant), and present the probable biological spectrum of major anti-oxidants from both plants.Entities:
Keywords: Duranta repens L.; Ficus benghalensis L.; anti-oxidant; cytotoxicity; docking
Year: 2020 PMID: 36120176 PMCID: PMC9476643 DOI: 10.1016/j.chmed.2020.02.004
Source DB: PubMed Journal: Chin Herb Med ISSN: 1674-6384
In-vitro anti-oxidant activity of hydroalcoholic extract of F. benghalensis and D. repens.
| IC50 of extracts/(µg·mL−1) | IC50of reference compounds/(µg·mL−1) | ||||
|---|---|---|---|---|---|
| Gallic acid | EDTA | Ascorbic acid | |||
| DPPH scavenging assay | 73.99 ± 2.22 | 70.90 ± 2.13 | − | − | 25.88 ± 4.847 |
| Hydrogen peroxide (H2O2) scavenging assay | 50.67 ± 1.77 | 47.71 ± 0.71 | − | − | 47.71 ± 0.71 |
| Nitric oxide (NO) scavenging assay | 69.02 ± 2.57 | 67.85 ± 4.25 | 55.66 ± 0.64 | − | − |
| Total anti-oxidant capacity (TAC) | 51.45 ± 1.23 | 53.86 ± 2.421 | − | − | 38.71 ± 2.54 |
| CUPRAC (Cu2+ to Cu+ reducing assay) | 55.51 ± 0.54 | 54.52 ± 2.93 | − | − | 38.02 ± 2.25 |
| Metal chelating assay | 55.95 ± 0.92 | 41.21 ± 0.69 | − | 23.12 ± 2.16 | − |
| ABTS scavenging assay | 45.73 ± 1.17 | 53.72 ± 2.13 | 30.75 ± 1.637 | − | − |
Cytotoxicity of hydroalcoholic extract of F. benghalensis and D. repens in cell lines.
| Cell lines | Test agents | IC50/(µg·mL−1) |
|---|---|---|
| CHO | 257.47 ± 3.60 | |
| 226.37 ± 15.19 | ||
| A549 | 193.78 ± 6.58 | |
| 104.02 ± 4.97 |
Fig. 1Biological spectrum of phytoconstituents from D. repens (A) and F. benghalensis (B).
Fig. 2Cytotoxicity of phytoconstituents from F. benghalensis (1) and D. repens (2) in cancer (a) and normal cell lines (b).
Binding affinity of phytoconstituents from F. benghalensis with targets related to ROS system.
| Phytoconstituents | Lipoxygenase (PDB:1N8Q) | Myeloperoxidase (PDB:1DNU) | Xanthine oxidase (PDB:3NRZ) | Cytochrome P450 (PDB:1OG5) | NAD(P)H oxidase (PDB:2CDU) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | |
| 3- | −9 | 3 | ARG786, GLY265, ASN146 | −10.9 | 1 | ALA389 | −8.4 | 2 | GLN102, LYS95 | −8.4 | 2 | TYR42, ARG377 | −9.8 | 1 | GLU163 |
| Mucusisoflavone C | −10.6 | 2 | THR274, ASM556 | −10.4 | 3 | THR292,THR296, THR168 | −7.7 | 3 | ASN71, THR52, ASN146 | −10.6 | 2 | THR30, GLY296 | −11.1 | 4 | ASN343, SER328, SER326 |
| wighteone | −2.6 | 2 | THR274 | −8.1 | 1 | GLU245 | −6.5 | 1 | GLU89 | −8.9 | 3 | PHE47, LEU20, GLN214 | −9.3 | 1 | LYS134 |
Note:BE: Binding energy in kcal/mol, NHB: number of hydrogen bonds, HBR: hydrogen bond residues.
Binding affinity of phytoconstituents from D. repens with targets related to ROS system.
| Phytoconstituents | Lipoxygenase (PDB:1N8Q) | Myeloperoxidase (PDB:1DNU) | Xanthine oxidase (PDB:3NRZ) | Cytochrome P450 (PDB:1OG5) | NAD(P)H oxidase (PDB:2CDU) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | BE | NHB | HBR | |
| Naringenin | −8.2 | 6 | THR274, TYR 275, ASM 556, ARG 260, ALA 263 | −8.3 | 0 | – | −7.1 | 1 | GLM144 | −8.4 | 2 | VAL113, SER365 | −8.4 | 3 | PRO 298,LYS 134,SER 41 |
| 3, 7-Dihydroxy-2-[4-hydroxy-3-(4-hydroxy-3-methylbutyl)phenyl]-5, 6-dimethoxy-4H-1-benzopyran-4-one | −8.1 | 3 | VAL 588, TYR 512, ASP 428 | −7.7 | 3 | SER174, ASP 172 | −7 | 5 | TYR58, GLY12, THR86, TYR125 | −8.2 | 2 | ALA103, ASN217 | −9 | 3 | LYS 134, ASP 282, ALA 300 |
| 7- | −7.9 | 2 | LYS156, ASP190 | −8.2 | 7 | ARG23, SER174, THR16, PHE170, SER169, THR329 | −7.2 | 7 | SER69, SER123, ALA142, GLY145, GLM144 | −9.4 | 5 | TRP120, ARG43, THR301, GLY296 | −9.1 | 2 | THR9,ALA300 |
Note: BE: Binding energy in kcal/mol, NHB: number of hydrogen bonds, HBR: hydrogen bond residues.
Fig. 33D (a) and 2D (b) interaction of 3-O-trans-p-coumaroyltormentic acid with myeloperoxidase (1) and 7-O-α-D-glucopyranosyl-3,5-dihydroxy-3′-(4′'-acetoxyl-3′'-methylbutyl)-6,4′-dimethoxyflavone with CYP450 (2).